QurAlis Closes $88 Million Series B to Advance Precision Medicines for Neurodegenerative Diseases



Comments are closed.

Cerevance Adds $47 Million in Series B-1 Extension to Advance Robust Clinical Pipeline
Element Solutions has acquired Kuprion, Inc.
AccuKnox Raises $6M in Seed Funding for Zero Trust CNAPP and KubeArmor OpenSource Project
Sea Machines Completes $20 Million Series B Fundraise